TY  - GEN
AU  - Kleinjan,Jan P
AU  - Brinkman,Ithamar
AU  - Bakema,Robbert
AU  - van Zanden,Jelmer J
AU  - van Rooijen,Johan M
TI  - Tolerance-based capecitabine dose escalation after DPYD genotype-guided dosing in heterozygote DPYD variant carriers: a single-center observational study
SN  - 1473-5741
PY  - 2020///0909
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Capecitabine
KW  - Dihydrouracil Dehydrogenase (NADP)
KW  - genetics
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Heterozygote
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Polymorphism, Single Nucleotide
KW  - Practice Guidelines as Topic
KW  - standards
KW  - Prognosis
KW  - Retrospective Studies
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Journal Article; Observational Study
UR  - https://doi.org/10.1097/CAD.0000000000000748
ER  -